Acute promyelocytic leukemia (APL) is characterized by specific chromosomal translocations, which generate fusion proteins such as promyelocytic leukemia (PML)-retinoic acid receptor (RAR)␣ and promyelocytic leukemia zinc finger (PLZF)-RAR␣ (X-RAR␣). In this study, we have applied lac operator array systems to study the effects of X-RAR␣ versus wild-type RAR␣ on large-scale chromatin structure. The targeting of these enhanced cyan fluorescent protein-lac repressor-tagged RAR␣-containing proteins to the gene-amplification chromosomal region by lac operator repeats led to local chromatin condensation, recruitment of nuclear receptor corepressor, and histone deacetylase complex. The addition of retinoic acid (RA) induced large-scale chromatin decondensation in cells expressing RAR␣; however, cells expressing X-RAR␣, especially PML-RAR␣, demonstrated insensitive response to this effect of all-trans retinoic acid (ATRA). Although we did not reveal differences in RA-dependent colocalization of either silencing mediator for retinoid and thyroid or steroid receptor coactivator (SRC)-1 with RAR␣ versus X-RAR␣, the hormone-independent association between SRC-1 and X-RAR␣ on the array has been identified. Rather, compared with cells expressing RAR␣, fluorescence recovery after photobleaching of live transfected cells, demonstrated decreased mobility of SRC-1 on the X-RAR␣-bound chromatin. Thus, the impaired ability of APL fusion proteins to activate gene transcription in response to ATRA corresponds to their reduced ability to remodel chromatin, which may link to their ability to impair the mobility of key nuclear receptor coregulators.
INTRODUCTION
The protein products that arise from chromosomal translocations are critical factors in carcinogenesis, especially in leukemia. Chromosomal translocations that occur in leukemic cells frequently involve genes for transcription factors, leading to the formation of chimeric proteins capable of interfering in cell signaling pathways that control important aspects of growth, differentiation, and survival within hematological cells (Look, 1997) . Acute promyelocytic leukemia (APL) comprises 10% of acute myeloid leukemia, and it is most commonly associated with the specific reciprocal chromosomal translocation involving the retinoic acid receptor (RAR) ␣ gene on chromosome 17 and the promyelocytic leukemia (PML) gene on chromosome 15 or the promyelocytic leukemia zinc finger (PLZF) gene on chromosome 11 (Melnick and Licht, 1999; Dong et al., 2003a) . These APL-specific chromosomal abnormalities generate PML-RAR␣ or PLZF-RAR␣ chimeric genes, which have been demonstrated to play a key role in leukemogenesis by interfering with differentiation of bone marrow myeloid cells, causing arrest at the promyelocyte stage (Zelent et al., 2001) .
Numerous studies have been performed with the goal of understanding how chimeric RAR␣-containing proteins contribute to leukemogenesis (Melnick and Licht, 1999; Zelent et al., 2001; Lallemand-Breitenbach et al., 2005) . A critical contribution to this process made by the RAR␣ fusion partners is the ability to mediate homodimerization or oligomerization of the chimeric protein (Kwok et al., 2006; Licht, 2006) . However, the precise consequences of homodimerization in terms of leukemogenesis remain uncertain. One possibility supported by substantial in vitro data is that homodimerization results in binding to retinoic acid response element (RARE) sites required for normal myeloid differentiation, thereby competitively inhibiting binding to these sites by normal RAR␣/retinoid X receptor (RXR) ␣ heterodimers. An alternative explanation is that homodimerized chimeric RAR␣-containing proteins interfere with expression of genes critical for normal myeloid differentiation by mislocalizing within the nucleus, resulting in spatiotemporal sequestration of nuclear coregulators essential for their expression (Dong et al., 2004) . Either spatiotemporal sequestration alone or competitive inhibition combined with the aberrant ligand-dependent interactions of X-RAR␣ with nuclear coactivators and corepressors may result in impaired chromatin remodeling and repression of transcription (Lin et al., 2001 ).
To explore the possibility in vivo that chimeric RAR␣-containing fusion proteins contribute to leukemogenesis by impairing chromatin remodeling at the single-cell level, we used lac operator-lac repressor tethering systems, A03_1 and RRE_B1 cells, which contain multiple integrated copies of a high-affinity-binding site for the lac repressor, to directly visualize the effect of wild-type RAR␣ compared with PML-RAR␣ and PLZF-RAR␣ (X-RAR␣) on large-scale chromatin dynamics. In A03_1 cell line system, multiple copies of the lac operator were engineered into the genome of Chinese hamster ovary (CHO) cells, and, together with the surrounding genomic sequences, they were amplified to produce a 90-Mb heterochromatic region or array (Robinett et al., 1996; Li et al., 1998) . The expression of a chimeric protein containing the lac repressor and the activation domain of viral transcription factor VP16 in these A03_1 cells resulted in recruitment of the protein to the lac operator array and large-scale chromatin decondensation (Belmont et al., 1999a; Tumbar et al., 1999; Belmont, 2001) .
Interrogation of the effects of wild-type RAR␣ versus X-RAR␣ gene products on chromatin structure by using this lac repressor-tethering system revealed that expression of either cyan fluorescent protein (CFP)-LacR-tagged wildtype RAR␣ or X-RAR␣ protein results in 60% condensation of the array. However, compared with wild-type RAR␣, cells expressing X-RAR␣ proteins, in particular PML-RAR␣, were insensitive to normalization of the array volume when exposed to all-trans retinoic acid (ATRA). This aberrant response to ATRA did not correlate with abnormalities in the ability of X-RAR␣ to modulate their association with nuclear coactivators or corepressors on the array; rather, it correlated with the reduced mobility of coactivators on the array compared with expression of wild-type RAR␣. Thus, the findings of this study support the hypothesis that expression of X-RAR␣ results in aberrant ATRA-mediated chromatin remodeling, possibly due to reduced mobility of critical nuclear coactivators.
MATERIALS AND METHODS

Reagents and Cell Lines
ATRA was obtained from Sigma-Aldrich (St. Louis, MO). A03_1 cell and RRE_B1 cells, which were kindly provided by Dr. Belmont (Robinett et al., 1996; Li et al., 1998) , were maintained at 37°C with 5% CO 2 in customized F-12 Ham's media with 10% dialyzed fetal bovine serum (FBS; HyClone Labs) and methotrexate (0.3 M for A03_1 cells and 10 M for RRE_B1 cells), without phenol red, hypoxanthine and thymidine (Li et al., 1998; Stenoien et al., 2001) . 293T cells were cultured in DMEM (Invitrogen, Carlsbad, CA) with 10% fetal bovine serum. HeLa cells were maintained in Opti-MEM I media (Invitrogen) with 4% FBS (Dong and Tweardy, 2002; Dong et al., 2004) .
Vector Constructs
The CFP-LacR construct was made by inserting the LacR (lac repressor) sequence, amplified from polymerase chain reaction (PCR)-reaction, into the BglII-digested pECFP-C1 (Clontech, Mountain View, CA). The CFP-LacR-RAR␣, CFP-LacR-PML-RAR␣, and CFP-LacR-PLZF-RAR␣ constructs were made by inserting the LacR fragment into constructs CFP-RAR␣, CFP-PML-RAR␣, and CFP-PLZF-RAR␣, respectively, described previously (Dong et al., 2004) . The silencing mediator for retinoid and thyroid (SMRT) and histone deacetylase 3 (HDAC3) cDNA fragments removed from a pCMX expression vector (Chen and Evans, 1995) and pcDNA3 expression vector (Invitrogen) (Yang et al., 1996) were subcloned into pEYFP-C1 vector (Clontech) to make yellow fluorescent protein (YFP)-tagged SMRT and YFP-tagged HDAC3 expression vector, respectively. The YFP-tagged steroid receptor coactivator (SRC)-1 and RXR␣ expression vectors (in pEYFP-C1; Clontech) have been reported previously (Stenoien et al., 2001; Dong et al., 2004) . The YFP-tagged RAR␣, PML-RAR␣, and PLZF-RAR␣ expression vectors were made from CFP-RAR␣, CFP-PML-RAR␣, and CFP-PLZF-RAR␣ (Dong et al., 2004) , respectively, by a swap involving placement of the cDNA for RAR␣, PML-RAR␣, and PLZF-RAR␣ into the pEYFP-C1 expression vector (Clontech). The YFP sequence within YFP-tagged SMRT vector was replaced with mCherry sequence from mCherry expression vector (in pRSET-B; Invitrogen) (Shaner et al., 2005) , to make cherry fluorescent protein (ChFP)-tagged SMRT expression vector. The fragment consisting of eight copies of lac operator (LacO) sequence, which was cut from vector p3216PECMS2␤ (Prasanth et al., 2005) , was placed into pGL3-promoter vector (Promega, Madison, WI) with appropriate restriction enzymes, to make 8ϫLacO luciferase reporter construct. All plasmid constructs were confirmed by DNA sequencing and immunoblotting ( Figure 1A ).
Cell Transfection, Immunoblotting, Luciferase Assay, and Gel-Shift DNA-Binding Assays For transient transfections, HeLa cells, 293T cells, A03_1 cells, and RRE_B1 cells were grown in six-well plates to 60 -70% confluence. The cells were transiently transfected with the indicated expression vectors, reporter genes, or a combination by using GeneJuice (Novagen, Madison, WI) as reported previously (Dong and Tweardy, 2002) . Twenty-four to 48 h after transfection, cells were lysed in lysis buffer for either immunoblotting or luciferase assay as described previously (Dong et al., 1996; Dong and Tweardy, 2002; Dong et al., 2003b Dong et al., , 2004 . Equivalent amounts of protein were electrophoresed on 7.5% SDS polyacrylamide gels and transferred to polyvinylidene difluoride membrane developed using antibody against RAR␣ (C-20; Santa Cruz Biotechnology, Santa Cruz, CA) or green fluorescent protein (GFP) (Dong et al., 2003b) .
For the gel-shift DNA-binding assays, CFP-tagged or CFP-LacR-tagged RAR␣, PML-RAR␣, and PLZF-RAR␣ proteins were expressed in 293T cells. Gel shift assays were performed as described previously (Dong et al., 1996; Dong and Tweardy, 2002) using 20 g of whole cell extracts of 293T cells transfected with the indicated constructs. Briefly, cell extracts were preincubated for 10 min at room temperature in the 20 l of reaction buffer, which contained 20 mM HEPES, pH 7.9, 0.5 mM EDTA, 2 mM dithiothreitol, 10% glycerol, 50 mM KCl, and 1 g of poly(dI-dC). Radiolabeled lac operator or RARE (DR5G) duplex oligonucleotide was added and incubated for 50 min. The lac operator double-stranded oligonucleotide contains the sequence (top strand) 5Ј-TGTGGAATTGTGAGCGGATAACAATT-3Ј (Sasmor and Betz, 1990) . The sequences of the RARE is as follows: 5Ј-GGGTAGGGGTCAC-CGAAAGGTCACTCG-3Ј (Dong et al., 1996) . One microgram of antibody against RAR␣ was included in the reaction for supershift experiments ( Figure  1 , C and D). Protein-DNA complexes were separated on 5% polyacrylamide gels equilibrated in 0.25ϫ Tris borate-EDTA. Gels were dried, exposed, and analyzed on the PhosphorImager (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom).
Fluorescence Microscopy and Fluorescence Recovery after Photobleaching (FRAP)
For fixed cell experiments, A03_1 and RRE_B1 cells were plated onto polyd-lysine-coated coverslips in 24-wells plate and cultured in customized F-12 Ham's media with 10% charcoal-dextran treated FBS (Hyclone Laboratories). After 24 h, cells were transfected with the indicated CFP-, YFP-, or ChFPlabeled constructs using GeneJuice (Novagen) as described previously (Dong et al., 2004) . Forty-eight hours after transfection, cells were fixed in 4% formaldehyde in PEM buffer [80 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid), pH 6.8, 5 mM EGTA, and 2 mM MgCl 2 ) and quenched in 1 mg/ml NaBH 4 (Sigma-Aldrich) in PEM buffer. The A03_1 and/or RRE_B1 cells were stained with 1 g/ml 4Ј,6Ј-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) for 5 min before mounting in Slow Fade reagent (Invitrogen). Deconvolution microscopy was performed on a Zeiss Axiovert S100 TV microscope (Carl Zeiss, Thornwood, NY) by using DeltaVision restoration and microscopy system (Applied Precision, Issaquah, WA) as described previously (Stenoien et al., 2000) . A series of Z-sections were imaged and deconvolved with the DeltaVision constrained iterative algorithm. For quantitative measurement, the DeltaVision software was used to measure the volume of the three-dimensional images of the LacO arrays of A03_1 cells, which were built by the software using the series of Z-sections of each array. The lac operator arrays within RRE_B1 cells were much more extended, and instead of measuring the volume of the array, the array occupied chromatin area was measured using the Z-section containing the largest array area. Both the volume and area measurements were exported, analyzed, and graphed in Excel (Microsoft, Redmond, WA).
For dual-FRAP analysis, cells were plated onto Delta T dishes (Bioptechs, Butler, PA) 24 h before transfection at a concentration of 2 ϫ 10 5 cells per dish. The expression of CFP-or YFP-tagged plasmids was performed using GeneJuice (Novagen) as described previously (Dong et al., 2004; Qiu et al., 2006) . FRAP was performed on the heated stage of an LSM 510 confocal laser scanning microscope (Carl Zeiss) with a 63ϫ, 1.4 numerical aperture Plan-Apochromat oil immersion objective. For both CFP and YFP fluorescent signals, the bleach was accomplished with the laser set at 458 and 514 nm and at 70% laser output for 30 iterations of a small circle of each lac operator array in A03_1 cells. Simultaneous images corresponding to the CFP and YFP fluorescence were obtained before and at different time intervals after the bleach by using the multitracking function of the microscope (typically 5 prebleach and 100 postbleach frames). Fluorescent intensities of regions of interest (ROI) were measured with LSM software, and exported to Excel for analysis. Fluorescent intensities of the ROI were corrected for background and normalized to the mean of the last three prebleach values by using the following equation for each time point: (ROI bleach,t Ϫ ROI background )/(ROI bleach, prebleach Ϫ ROI background ). The normalized recovery curve was adjusted so that the lowest point in the curve was assigned a value of 0, and the highest point was assigned a value of 1. The t 1/2 of observed recovery was defined as the time required for reaching half-maximum recovery, and it was calculated from the normalized recovery curve. 
Statistical Analysis
LacO array volume and area data were transformed by taking logarithms to stabilize variances and reduce skewness. Summary statistics (geometric means and 95% confidence intervals) on the raw scale were computed by back-transforming the means and 95% confidence intervals of the transformed data. One-way analysis of variance (ANOVA) was used to determine whether there were any differences between groups, followed by specific linear contrasts to identify which groups differed. Analyses were conducted with SAS, version 9.1 (SAS Institute, Cary, NC).
RESULTS
Generation of Functional CFP-LacR-tagged Wild-Type RAR␣ and X-RAR␣
To study the intracellular function of wild-type RAR␣, PML-RAR␣, and PLZF-RAR␣ in the context of chromatin at the single-cell level, we created vectors expressing CFP-LacR (lac repressor) chimeras fused to the N-terminal ends of RAR␣, PML-RAR␣, and PLZF-RAR␣. Immunoblot analysis of whole cell extracts from transfected 293T cells showed that all CFP-LacR-tagged constructs encoded proteins of expected size ( Figure 1A ). To determine whether these CFPLacR-tagged proteins could bind to lac operator DNA sequence contained within the lac operator array in A03_1 and RRE_B1 cell lines (Li et al., 1998) , we performed gel-shift assays by using radiolabeled lac operator duplex oligonucleotide. As expected, all of the CFP-LacR-tagged proteins tested bound to lac operator duplexes and could be supershifted by antibody against RAR␣ ( Figure 1B ). To be certain that the addition of CFP-LacR to RAR␣, PML-RAR␣, or PLZF-RAR␣ did not significantly alter the functional characteristics of the RAR␣-containing portion of the construct, we examined the DNA binding activity of each using gelshift assays with RARE (DR5G); each bound to RARE not only as a homo-oligomer, but also as a hetero-oligomer with RXR␣, similar to results reported by us and other investigators with each of the untagged counterparts ( Figure 1 , C and D) (Dong and Tweardy, 2002; Zeisig et al., 2007) . In addition, these RAR␣-related hetero-oligomer and homo-oligomer complexes were further studied using the LacO array, A03_1 cell system. A03_1 cells were cotransfected with CFP-LacRtagged RAR␣, PML-RAR␣, and PLZF-RAR␣ plus their YFPtagged counterpart or YFP-tagged RXR␣ (Supplemental Figure 1) . As expected, YFP-tagged RXR␣ bound to all of CFP-LacR-tagged RAR␣ constructs bound to the array (Supplemental Figure 1A ). Also, YFP-tagged X-RAR␣ (PML-RAR␣ and PLZF-RAR␣) were able to form homo-oligomer complexes with their respective CFP-LacR-tagged counterpart bound to the array (Supplemental Figure 1 , C and D) in contrast to YFP-tagged wild-type RAR␣, which did not bind to CFP-LacR-RAR␣ bound to arrays ( Figure 1B ). These results confirm at the single-cell level previous in vitro studies by us and others (Dong et al., 1996; Dong and Tweardy, 2002; Kwok et al., 2006; Zeisig et al., 2007) .
To assess whether CFP-LacR-tagged proteins could bind the lac operon and activate transcription in an RAR␣ liganddependent manner, we examined the transcriptional activity of CFP-LacR-RAR␣ and CFP-LacR-X-RAR␣ by using a luciferase reporter system described previously (Dong et al., 1996; Dong and Tweardy, 2002) modified to contain multiple copies of the lac operator. HeLa cells were cotransfected with expression plasmid containing CFP-LacR-RAR␣ ( Figure 1E , lanes 1 and 2), CFP-LacR-PML-RAR␣ ( Figure 1E , lanes 3 and 4), CFP-LacR-PLZF-RAR␣ ( Figure 1E , lanes 5 and 6), or control CFP-LacR ( Figure 1E , lanes 7 and 8) plus the 8ϫlac operator-containing luciferase reporter vector in the absence or presence of ATRA, a ligand for RAR␣. The transcriptional activities of the CFP-LacR-RAR␣ and CFP-LacR-X-RAR␣ were shown to be retinoic acid inducible-ninefold by wildtype RAR␣, fivefold by PML-RAR␣, and 12-fold by PLZF-RAR␣. Of note, in the absence of ATRA, CFP-LacR-RAR␣ could activate this reporter twofold ( Figure 1E , lane 1 vs. lane 7), whereas PML-RAR␣ and PLZF-RAR␣ repressed basal activation of this reporter by two-and threefold, respectively. These results are in agreement with those published by us and other investigators using untagged RAR␣ and X-RAR␣ and a luciferase reporter construct driven by the RAR␤2 promoter (Dong et al., 1996 (Dong et al., , 2003b Dong and Tweardy, 2002) . Finally, we examined whether the addition of LacR altered the cellular localization of RAR␣ or X-RAR␣. After transient expression in HeLa cells, each LacR-tagged protein localized predominantly within the nucleus in a pattern identical to that reported previously by us for their CFP-tagged counterparts ( Figure 1F ) (Dong et al., 2004) . Thus, addition of the LacR tag conferred the ability of the LacR-tagged proteins could bind to a lac operator containing reporter construct and to activate transcription in a liganddependent manner, but it did not interfere with the RARE binding ability of CFP-RAR␣ and CFP-X-RAR␣ nor with their cellular localization and distribution.
Effect of CFP-LacR-RAR␣ and CFP-LacR-X-RAR␣ Binding on the lac Operator Array
To assess the effect of wild-type RAR␣ versus PML-RAR␣ or PLZF-RAR␣ on large-scale mammalian chromatin structure at the single-cell level, we made use of a CHO cell line, A03_1, in which multiple copies of the lac operator were engineered to produce an integrated 90-Mb heterochromatic array within the genome (Li et al., 1998) . The molecular organization of this array consists of 400-kb repeats of the 14-kb vector insert that contains the lac operator repeat and the dihydrofolate reductase selectable marker (Robinett et al., 1996; Li et al., 1998) . This lac operator array system has been applied by Dr. Belmont's group for studying the transcriptional responses of chromatin structure during transcriptional activation with enhanced green fluorescent protein (EGFP)-lac repressor (LacR)-VP16 (Tumbar et al., 1999) , which is a potent viral transcription activator protein, and EGFP-lac repressor-estrogen receptor (ER) (Nye et al., 2002) . Targeting this VP16 fusion protein to the lac operator array in A03_1 cells resulted in visualization of chromatin decondensation within 15 min, accompanied by the recruitment of histone acetyltransferases and by histone hyperacetylation (Tumbar et al., 1999) . In our studies, CFP-LacR transiently transfected into A03_1 cells distributed almost exclusively on the array consistent with high-affinity binding of LacR to the LacO and the previous results of others (Li et al., 1998; Stenoien et al., 2001 (Figure 2 ). Similar to CFP-LacR, CFP-LacR-RAR␣, and CFP-LacR-X-RAR␣ (CFP-LacR-PML-RAR␣, and CFP-LacR-PLZF-RAR␣) proteins transiently expressed in A03_1 cells each were distributed almost exclusively on the array. However, in contrast to CFP-LacR, the array volumes in cells transfected with CFP-LacR-RAR␣ (7.19 m 3 ; 95% CI ϭ 5.91-8.76), CFP-LacR-PML-RAR␣ (7.38 m 3 ; 95% CI ϭ 6.35-8.58), and CFP-LacR-PLZF-RAR␣ (7.42 m 3 ; CI ϭ 6.22-8.85) were reduced in each instance by ϳ60% within cells untreated with ligand (p Ͻ 0.001 for each). To confirm these results in a cell line containing a lac operator array that is more euchromatin-like, we repeated the experiment using the RRE_B1 cell line. The RRE_B1 cell line, like A03_1, is derived from CHO cells, and it contains amplified genomic domains consisting of lac operator bind- ing sites, in an extended, often fibrillar conformation (Robinett et al., 1996; Verschure et al., 2005) . Previous studies that targeted an EGFP-LacR-HP1 construct onto this array caused local chromatin condensation (Verschure et al., 2005) . Identical to our results with A03_1 cells, we observed array condensation in RRE_B1 cells transfected with each CFPLacR-RAR␣-containing construct compared with CFP-LacR (Supplemental Figure 2) . Thus, results in both array-containing cell lines are consistent with the hypothesis that wildtype RAR␣, PML-RAR␣, and PLZF-RAR␣ each recruit corepressors with histone deacetylase activity ( Figure 3B ).
Addition of 10 Ϫ7 M ATRA to cells containing CFP-LacR-RAR␣ increased the array volume by twofold consistent with release of corepressors and/or recruitment of coactivators with histone acetylase activity (Figure 2 ). In contrast, addition of 10 Ϫ7 M ATRA to cells expressing CFP-LacR-PML-RAR␣ or CFP-LacR-PLZF-RAR␣ did not increase the array volume (Figure 2) . Increasing the ATRA concentration to 10 Ϫ6 M did not increase the array volume in cells containing CFP-LacR-PML-RAR␣, but it did increase the array volume in cells containing CFP-LacR-PLZF-RAR␣ by 64% to a value indistinguishable from the array volume in cells expressing CFP-LacR-RAR␣ and incubated in 10 Ϫ6 M ATRA (Figure 2 ). Very similar results were obtained by using euchromatin-like RRE_B1 cell line (Supplemental Figure 2) . The finding that the arrays in cells expressing CFP-LacR- PML-RAR␣ were more resistant to the ATRA-induced increase in volume than arrays in cells expressing CFP-LacR-PLZF-RAR␣ was somewhat unexpected based on results of clinical studies demonstrating that APL patients with PML-RAR␣-positive disease are ATRA responsive, whereas patients with PLZF-RAR␣-positive disease are ATRA resistant (Melnick and Licht, 1999; Zelent et al., 2001) .
We and others have reported that the protein products of X-RAR␣ fusion genes were degraded within cells upon retinoic acid treatment (Koken et al., 1999; Melnick and Licht, 1999; Dong and Tweardy, 2002) . To assess whether differences in protein stability participated in the variable ATRAinduced increase in array volumes, we performed immunoblotting analysis of whole cell extracts from cells transiently transfected with CFP-LacR-tagged RAR␣ and X-RAR␣ before and after ATRA treatment (Supplemental Figure 3) . The level of each of the RAR␣-containing proteins in A03_1 cells incubated with ATRA was virtually unchanged, indicating that ATRA-mediated changes in protein stability did not contribute to changes in array volumes.
Effect of CFP-LacR-RAR␣ and CFP-LacR-X-RAR␣ Expression and ATRA on the Distribution of Nuclear Receptor Corepressor SMRT and Coactivator SRC-1 within A03_1 Cells
The lac operator array A03_1 cell system has been used previously to study nuclear receptor biology (Stenoien et al., 2001) , and it revealed interactions between the ER and both SRC-1 and CREB-binding protein (CBP) on the array within A03_1 cells. Transient triple-transfection of A03_1 cells with CFP-LacR-tagged RAR␣ or X-RAR␣ plus YFP-SRC-1 and ChFP-SMRT construct established that each nuclear receptor coregulator demonstrated ATRA-dependent interactions with each CFP-LacR-tagged RAR␣-containing construct on the lac operator array in the expected manner, confirming earlier studies at the single-cell level (Supplemental Figure 4) .
To determine whether the tagged RAR␣-containing constructs recruited nuclear corepressors to the array and whether this contributed to ATRA-induced changes in the lac operator array volume, we imaged A03_1 cells coexpressing YFP-SMRT and each of the CFP-LacR-containing constructs. Coexpression of YFP-SMRT and CFP-LacR in cells untreated with ATRA revealed CFP-LacR localized to the array, whereas YFP-SMRT distributed diffusely throughout the nucleus, and it did not colocalize with CFP-LacR on the array (data not shown). In contrast, coexpression of YFP-SMRT and CFP-LacR-RAR␣ in A03_1 cells untreated with ATRA revealed virtually all the YFP-SMRT colocalized with CFP-LacR-RAR␣ on the array ( Figure 3A ) consistent with findings summarized above of smaller array volumes in cells expressing CFP-LacR-tagged RAR␣ versus CFP-LacR alone. Treatment of these cotransfected cells with ATRA at either 10 Ϫ7 or 10 Ϫ6 M resulted in partial or complete dissociation of YFP-SMRT from the array, which correlated with the increase in array volume observed in cells transfected with CFP-LacR-RAR␣ and treated with ATRA at these concentrations ( Figure 3A) . Coexpression of YFP-SMRT with either CFP-LacR-PML-RAR␣ or CFP-LacR-PLZF-RAR␣ in A03_1 cells untreated with ATRA resulted in virtually all the YFP-SMRT colocalized with CFP-LacR-X-RAR␣ on the array ( Figure 3A) . Unexpectedly, treatment of both sets of cotransfected cells with ATRA at either 10 Ϫ7 or 10 Ϫ6 M revealed partial or complete dissociation of YFP-SMRT from the array, similar to the results obtained with ATRA-treated cells cotransfected with YFP-SMRT and CFP-LacR-RAR␣. Thus, YFP-SMRT associated with RAR␣-containing constructs on the arrays and this association correlated to array volumes in the absence of ATRA. Furthermore, ATRA-induced dissociation of YFP-SMRT from the array correlated well with the ATRAinduced increase in array volume in cells expressing CFP- LacR-tagged wild-type RAR␣; however, this was not the case for cells expressing either CFP-LacR-PML-RAR␣ or CFP-LacR-PLZF-RAR␣.
HDAC3 is known to form SMRT-HDAC3 functional complexes (Li et al., 2002) . Examination of A03_1 cells cotransfected with the CFP-LacR construct revealed HDAC3 present at very low levels in the amplified chromosomal region (data not shown). A03_1 cells cotransfected with YFP-HDAC3 and either CFP-LacR-RAR␣ or CFP-LacR-X-RAR␣ demonstrated virtually all of the YFP-HDAC3 partially colocalized to the lac operator array in the absence of ATRA ( Figure 3B ). After addition of ATRA, YFP-HDAC3 completely dissociated from the array. Thus, YFP-HDAC3 followed the identical pattern of array colocalization as YFP-SMRT.
To determine whether the tagged RAR␣-containing constructs recruited nuclear coactivators to the array and whether this contributed to changes in the lac operator array volume, we imaged A03_1 cells coexpressing YFP-SRC1 and CFP-LacR, CFP-LacR-RAR␣, CFP-LacR-PML-RAR␣ or CFPLacR-PLZF-RAR␣. Coexpression of YFP-SRC-1 and CFPLacR in A03_1 cells revealed CFP-LacR localized to the array, whereas YFP-SRC-1 distributed diffusely throughout the nucleus; no colocalization of YFP-SRC-1 with CFP-LacR on the array was observed (data not shown). Coexpression of YFP-SRC-1 and CFP-LacR-RAR␣ in A03_1 cells untreated with ATRA revealed CFP-LacR-RAR␣ localized to the array, and most of the YFP-SRC-1 distributed diffusely throughout the nucleus ( Figure 3C ). Examination of cotransfected cells treated with ATRA at either 10 Ϫ7 or 10 Ϫ6 M revealed nearly complete localization of YFP-SRC-1 on the array, which correlated well with the increase in array volume observed in cells transfected with CFP-LacR-RAR␣ summarized above ( Figure 3C ). Coexpression of YFP-SRC-1 with either CFP-LacR-PML-RAR␣ or CFP-LacR-PLZF-RAR␣ in A03_1 cells untreated with ATRA resulted in YFP-SRC-1 distributed diffusely throughout the nucleus. However, the increasing complete binding of coactivator SRC-1 into X-RAR␣-bound chromatin area (23% PML-RAR␣-and 44% PLZF-RAR␣-expressing cells, in contrast to only 7% wild-type RAR␣-expressing cells) was observed, indicating a ligandindependent association between SRC-1 and X-RAR␣ ( Figure  3C ). Treatment of both sets of cotransfected cells with ATRA at either 10 Ϫ7 or 10 Ϫ6 M revealed nearly complete localization of YFP-SRC-1 on the array, again similar to the results with cells cotransfected with YFP-SRC-1 and CFP-LacR-RAR␣. Thus, ATRA treatment of cotransfected A03_1 cells induced association of SRC-1 with all tagged RAR␣ constructs on the array. Furthermore, although ATRA-induced colocalization of YFP-SRC-1 with CFP-LacR-tagged constructs on the ar- rays correlated with an increase in array volume in cells expressing tagged wild-type RAR␣, this was not the case for either tagged PML-RAR␣ or PLZF-RAR␣. Thus, when assessed at the single-cell level, neither association nor dissociation of either SMRT/HDAC3 or SRC-1 was sufficient to explain differences in ATRA-induced array volumes between wild-type RAR␣ and X-RAR␣.
Nuclear Mobility of YFP-SRC-1 and YFP-SMRT in A03_1 Cells Expressing CFP-LacR-RAR␣ or CFP-LacR-X-RAR␣
We previously demonstrated that X-RAR␣ protein expression resulted in aberrant localization and reduced mobility of key nuclear receptor coregulators (Dong et al., 2004) . To assess whether reduced mobility of nuclear receptor corepressors contributed to aberrant ATRA-mediated chromatin remodeling in cells expressing X-RAR␣, we performed dual-FRAP of A03_1 cells cotransfected with YFP-SMRT and CFP-LacR-tagged wild-type RAR␣ or X-RAR␣. In the absence of ATRA, the mobility for YFP-SMRT is very slow (t 1/2 Ͼ 10 min; data not shown). However, as shown in Figure 3A , treatment with ATRA at 10 Ϫ7 M for 3 h resulted in nearly complete dissociation of YFP-SMRT from CFPLacR-tagged RAR␣ and X-RAR␣ on the array. To obtain measurable recovery times, cells were examined after treatment with ATRA at this concentration for 30 min; nuclei selected for analysis were those in which the YFP signal was both on and off the array. After the 2-s bleach, there was little or no recovery of the CFP signal over 99 s ( Figure 4A ) or even over 20 min (data not shown), indicating that the LacR-containing proteins were essentially immobilized on the array due to the high-affinity binding of the lac repressor domain to the lac operator sites within the array. The mobility of YFP-SMRT localized on the CFP-LacR-RAR␣-bound array assessed by its recovery t 1/2 was 13.57 Ϯ 4.53 s, whereas the mobility of nonarray bound YFP-SMRT was very fast with recovery t 1/2 ϭ 0.69 Ϯ 0.14 s ( Table 1 ). The mobility of YFP-SMRT localized on the CFP-LacR-PML-RAR␣-bound array was essentially identical to that for CFPLacR-RAR␣ (t 1/2 ϭ 13.50 Ϯ 4.21 s). In contrast, the mobility of YFP-SMRT on the CFF-LacR-PLZF-RAR␣-bound array was reduced by 68% (t 1/2 ϭ 22.76 Ϯ 7.87 s; p Ͻ 0.001; Figure  4A and Table 1 ) compared with YFP-SMRT on the CFRLacR-RAR␣-bound array, indicating that YFP-SMRT bound more tightly to PLZF-RAR␣ than to wild-type RAR␣. We demonstrated reduced intranuclear mobility of SMRT bound to PLZF-RAR␣, which most likely reflects increased binding affinity of SMRT to PLZF-RAR␣ compared with either wild-type RAR␣ or PML-RAR␣. The biochemical and molecular basis for a higher affinity interaction between SMRT and PLZF-RAR␣ in vitro has been attributed to the PLZF POZ domain (Dong et al., 1996; Lin et al., 1998) . Although consistent with these in vitro findings, our in vivo results do not explain the resistance to the ATRA-induced increase in array volumes in cells expressing both X-RAR␣, in particular PML-RAR␣ (Figure 2) .
To assess whether reduced mobility of nuclear receptor coactivators contributed to aberrant ATRA-mediated chromatin remodeling in cells expressing X-RAR␣, we performed dual FRAP over the array in A03_1 cells coexpressing YFP-tagged coactivator SRC-1 and CFP-LacR-tagged wild-type RAR␣ or X-RAR␣. Cells with YFP signal mostly on the array after treatment with ATRA at 10 Ϫ7 M for 30 min were chosen for analysis. After the 2-s bleach, the CFP signal had no or little recovery as expected ( Figure 4B ). The mobility of YFP-SRC-1 not bound to the array is fast (recovery t 1/2 ϭ 1.11 Ϯ 0.22 s). However, the mobility of YFP-SRC-1 localized on the CFP-LacR-RAR␣-bound array was slower (t 1/2 ϭ 17.80 Ϯ 4.31 s; Table 1 ) and even slower in cells containing CFP-LacR-PML-RAR␣-bound arrays (t 1/2 ϭ 26.07 Ϯ 8.35 s; Table 1 ; p Ͻ 0.001) and in cells containing CFF-LacR-PLZF-RAR␣-bound arrays (t 1/2 ϭ 25.80 Ϯ 9.89 s; Table 1 ; p Ͻ 0.001). These results indicate that YFP-SRC-1 bound more tightly to X-RAR␣ than to wild-type RAR␣. Thus, reduced mobility of YFP-SRC-1 on X-RAR␣-bound arrays correlated with resistance to the ATRA-induced increase in array volumes.
DISCUSSION
We used two integrated lac operator array cell systems (Belmont et al., 1999b) to examine the hypothesis at the singlecell level that RAR␣-containing APL fusion proteins remodel chromatin aberrantly compared with wild-type RAR␣. Fluorescent microscopic examination of arrays after expression of CFP-LacR-tagged, RAR␣-containing proteins demonstrated that each of the tagged proteins bound to arrays resulting in condensation of the array volume to less than half that of arrays bound by lac repressor alone. All-trans retinoic acid treatment resulted in array decondensation in cells expressing tagged wild-type RAR␣. However, cells expressing tagged X-RAR␣ were insensitive to the array-decondensing effect of ATRA at different level (Figure 2 ).
Eukaryotic cells use multiple steps at several structural levels to effectively package their genome within the nucleus. It is now well established that unpacking or remodeling of chromatin structure locally is a critical step in the initiation of multiple chromosome functions notably transcription (Belmont et al., 1999a) . Whereas intense research in the past decade has provided a wealth of information regarding the biochemical basis for ligand-dependent transcriptional properties of RAR␣ (Chambon, 1995) , much less is known about reorganization of local chromatin structure by RAR␣ protein and how this compares with X-RAR␣ oncogenic proteins. Our studies are the first to report the effects of RAR␣-containing fusion proteins on chromatin structure and nuclear receptor coregulator recruitment in vivo at the single-cell level. The finding that expression of LacR-tagged RAR␣ within lac repressor-tethering cell systems in the absence of ligand results in lac operator array condensation is consistent with in vitro evidence that, in the absence of ligand, RAR␣ can recruit corepressor with histone deacetylase activity (Melnick and Licht, 1999) . Cotransfection of lac operator array-containing cells with CFP-LacR-RAR␣ and YFP-SMRT or YFP-HDAC3 confirmed this at the (Licht, 2001 (Licht, , 2006 Zelent et al., 2001; Melnick et al., 2002) . Examination of lac operator array-containing cells cotransfected with CFP-LacR-RAR␣ and YFP-SMRT or YFP-SRC-1 as well as cells transfected with all three constructs revealed that the addition of ATRA resulted in both the release of SMRT from the RAR␣-bound lac operator array and the recruitment of coactivator SRC-1 at the single-cell level. These studies provide intriguing insight at the single-cell level regarding how APL fusion proteins may function as oncogenes. Similar to wild-type RAR␣, expression of both PML-RAR␣ and PLZF-RAR␣ proteins in lac repressor-tethering systems resulted in lac operator array condensation. In the absence of ligand, each also was shown to recruit nuclear receptor corepressor SMRT to the array, thereby confirming in vivo at the single-cell level previous in vitro studies that demonstrated the ability of corepressor to bind to APL fusion proteins in the absence of ligands (Lin et al., 1998; Dong and Tweardy, 2002) . However, somewhat unexpectedly, based on previously reported responses in APL patients to ATRA (Melnick and Licht, 1999) , cells containing PML-RAR␣ were more, not less, insensitive to ATRA-induced chromatin decondensation compared with cells containing PLZF-RAR␣. In addition, the complete dissociation of corepressor SMRT from PLZF-RAR␣-bound chromatin area in retinoic acid (RA)-treated cells was observed, which was in line with the RA-dependent transactivation effect by this tagged PLZF-RAR␣, although we found the decreased SMRT nuclear mobility with chromatin-bound PLZF-RAR␣ in comparison with that with wild-type RAR␣ or PML-RAR␣. The integration of our data with earlier findings, in which RA treatment led to PLZF-RAR␣ degradation (Koken et al., 1999; Dong and Tweardy, 2002) , strongly suggests that PLZF-RAR␣ chimeric protein responds well to the treatment of retinoic acid. However, these effects were not accompanied by terminal differentiation or apoptosis of APL cells (Koken et al., 1999) . These findings suggest that the molecular basis for differences in clinical response to ATRA for these two forms of APL may lie beyond differences in ATRA-mediated changes in large-scale chromatin remodeling. Combined with the transgenic studies (He et al., 2000) , in which, Pandolfi's group found that double transgenic mice with RAR␣-PLZF and PLZF-RAR␣ but PLZF-RAR␣ alone developed leukemia with typical APL features, our single-cell studies highlighted the importance of reciprocal RAR␣-PLZF fusion protein, whose mRNA was existed in all t(11;17) APL patients (Melnick and Licht, 1999) , in leukemogenesis as well as clinical RA resistance.
There is growing evidence that the dynamic exchange of proteins on chromatin is essential for transcriptional activators to gain access to chromatin and that controlling the exchange rate of a protein on chromatin might contribute to regulation of gene expression (Misteli, 2001 ). Although we found evidence of ATRA dependence of SMRT and SRC-1 interactions with APL fusion proteins in vivo using lac repressor-tethering system as reported previously in vitro (Lin et al., 1998; Dong and Tweardy, 2002) , no differences were observed in the ATRA concentration dependence of the interactions of either SMRT or SRC-1 with X-RAR␣ compared with wild-type RAR␣ that would explain differences in ATRA-induced array decondensation. However, we found that chromatin-bound X-RAR␣ (PML-RAR␣ and PLZF-RAR␣) fusion proteins associated with nuclear receptor coactivator SRC-1 in a retinoic acid-independent way. Furthermore, the impaired ATRA-dependent decondensation in cells expressing X-RAR␣ correlated with reduced intranuclear mobility of SRC-1. Reduced intranuclear mobility presumably is due to increased binding affinity of SRC-1 to PML-RAR␣ and PLZF-RAR␣. In line with our studies, very recently, Dr. Kao's group demonstrated that PML-RAR␣ oncogenic protein aberrantly interacts with nuclear receptor coactivator SRC-3 and CBP in a hormone-independent manner, which correlate with the ability of PML-RAR␣ to decrease the transcriptional activation by the glucocorticoid receptor and Notch signaling pathway (Reineke et al., 2007) . By binding nuclear receptor coactivators such as SRC-1, SRC-3, and CBP with higher affinity than wild-type RAR␣, APL fusion proteins may contribute to transcriptional alterations resulting in diseases by reducing the availability of these coactivators to bind to sites on chromatin important for maintaining the normal transcriptome of the cell.
